Company intelligence / Profile preview

Lynderm Research

Markham, Ontario, Canada

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Lynderm Research has completed over 300 clinical trials in dermatology, supporting Phase 2 and earlier studies in a wide range of skin disorders including atopic dermatitis, psoriasis, acne, vitiligo, and more. They routinely act as a top Canadian investigator site and have ongoing trials for biologics, JAK inhibitors (e.g., ruxolitinib for topical use), and innovative dermatological therapies.[2][3][4][9][11]

Therapeutic areas: ImmunologyInfectious DiseasesDermatologyRheumatology
Modalities: Small moleculeBiologicMonoclonal antibodyTopical therapyDevice
Industry: Contract Research Organization

Partnerships

Collaborates with major pharmaceutical companies on clinical trials

Beyond the preview

Go deeper on Lynderm Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lynderm Research.

Explore the full profile